Glenmark makes rare appearance for $175m loan

natural_medicine_adobe_575x375.jpg
By Pan Yue
22 Sep 2020

India’s Glenmark Pharmaceuticals has returned to the loan market after an absence of more than 10 years. It is seeking a $175m deal.

Barclays and ING are the mandated lead arrangers and bookrunners for the facility, according to a banker who received the invitation.

The loan has a tenor of 3.5 years, and pays a margin of 315bp over Libor. Two ticket levels are up for grab. Banks committing $20m and above receive a 70bp ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial